protein

Recombinant Cynomolgus Monkey B7-1/CD80 His-tag Protein, CF

9244-B1-100

100 ug

443 USD

9244-B1-100

Recombinant Cynomolgus Monkey B7-1/CD80 His-tag Protein, CF

100 ug

The Recombinant Cynomolgus Monkey B7-1/CD80 His-tag Protein, CF from R&D Systems is derived from HEK293. The Recombinant Cynomolgus Monkey B7-1/CD80 His-tag Protein, CF has been validated for the following applications: Bioactivity.

B7-1/CD80

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Cynomolgus Monkey

35-45 kDa, reducing conditions

25 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey B7-1/CD80 is immobilized at 0.5 ╡g/mL (100 ╡L/well), the concentration of Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT ) that produces 50% of the optimal binding response is approximately 5-30 ng/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

Recombinant Cynomolgus Monkey B7-1/CD80 His-tag Protein Binding Activity

XP_005548122

Bioactivity

Human embryonic kidney cell, HEK293-derived cynomolgus monkey B7-1/CD80 protein Val35-Asn242, with a C-terminal 6-His tag

HEK293

443 USD

Activation B7-1 antigen, B7, B71, BB1, CD28LG1, CD28LGB7-1 antigen), CD80, CD80 antigen, CD80 molecule, costimulatory factor CD80, costimulatory molecule variant IgV-CD80, CTLA-4 counter-receptor B7.1, T-lymphocyte activation antigen CD80

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.